Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome

Hepatology

Volumn 23, Issue 6, 1996, Pages 1448-1455

  Acharya, S K ^a   Dasarathy, S ^a   Kumer, Tali L ^a   Sushma, S ^a   Prasanna, K S Uma ^a   Tandon, A ^a   Sreenivas, V ^a   Nijhawan, S ^a   Panda, S K ^a   Nanda, S K ^a   Irshad, M ^a   Joshi, Y K ^a   Duttagupta, S ^a   Tandon, R K ^a   Tandon, B N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BRAIN EDEMA; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DISEASE COURSE; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; LIVER FAILURE; LIVER SIZE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; RISK FACTOR; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 15844397765     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008675163     Document Type: Article

References (16)

1. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.
2. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-275.
3. Takahashi Y, Shimizu M. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentric study. J Gastroenterol Hepatol 1991;6:159-164.
4. Muto Y. Present status of fulminant hepatitis in Japan (1989-1991) Gastroenterol Jpn 1993;28(suppl 4):120-127.
5. Bernuau J, Rueff B, Benhmaou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986;6:97-106.
6. Rakela J. Etiology and prognosis in fulminant hepatitis: acute hepatic failure study group [Abstract]. Gastroenterology 1979;77:A33.
7. Christensen E, Bremmelgaard A, Bahnsen M, Anderson PB, Tygstrup N. Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol 1984;19:90-96.
8. Tygstrup N, Ranek L. Assessment of prognosis in fulminant hepatic failure. Semin Liver Dis 1986;6:129-137.
9. Sherlock S. Acute liver failure. In: Sherlock S, ed. Diseases of liver. Ed 9. Oxford, England: Blackwell Scientific Publication, 1992.
10. Karvountzis GG, Redeker AG. Relation of alpha fetoprotein in acute hepatitis to severity and prognosis. Ann Intern Med 1974;80:156-160.
11. Scotto J, Opolon I, Eteve J, Vergoz D, Mand T, Caroli J. Liver biopsy and prognosis in acute liver failure. Gut 1973;14:927-933.
12. Trey C, Davidson C. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in liver disease. Vol 3. New York: Grune and Stratton, 1970:282-298.
13. Gimson AES, White YS, Eddleston ALWF, Williams R. Clinical and prognostic differences in fulminant hepatitis type A, B and nonA nonB. Gut 1983;24:1194-1198.
14. Gazzard BG, Portmann B, Iain M, Murray L, Williams R. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med 1975;94:615-626.
15. Kumara T, Muto Y, Moriwaki H, Yoshida T, Tomita E. Determination of the integrated CT number of the whole liver in patients with severe hepatitis: as an indicator of the functional reserve of the liver. Gastroenterologica Japonica 1989;24:290-297.
16. Pauwels A, Kara NM, Florent C, Levy VG. Emergency liver transplantation for acute liver failure. J Hepatol 1993;17:124-127.